Erlotib 150 mg Tab (Erlotinib)

Erlotib 150 mg Tab (Erlotinib)

Erlonat is administered to the patients who are suffering from lung cancer or metastatic lung cancer which is now at advanced stage. It is also being given to the patients having pancreatic cancer with the combination of other drugs. As this medicine is considered as a tyrosine kinase inhibitor which is usually prescribed for lung cancer.

As Erlotinib is tyrosine kinase inhibitor, it kills the affected cancer cells during the process by preventing the growth of them.  This is the reason this tablet is not prescribed for hypersensitive patient or platinum based chemotherapy patient.

 Substitutes Available 

1. Erlonat 150mg Tab (by Natco Pharma Ltd.)
   

 Side Effects 

1. Abdominal pain
2. Cough
3. Fatigue
4. Diarrhea
5. Muscle pain
6. Fever
7. Breathlessness
8. Vomiting
9. Weight loss

 Safety 

1. Pregnancy - Consult your doctor 
2. Breastfeeding - Consult your doctor
3. Allergy - Contraindicated if allergic to Erlotinib or any other ingredient